Ipsos Reports H1 Revenue and Organic Growth
July 25 2019
Ipsos has generated revenue of EUR 903.4m in the first half of 2019, up 14.9% compared with the first six months of 2018. Organic growth for the half year was 3.0%.
During the second quarter, Ipsos saw revenue climb 14.9% to EUR 481.5m, with all areas of the business contributing. Scope effects (acquisitions) amounted to 10.2%, while the currency effect was positive at 2.4%.
Performance by Region
Performance by Region
Breakdown of consolidated revenue by region
(In millions of Euros) |
H1 2019 |
H1 2018 |
YoY H1 change |
Organic growth |
|
Europe, Middle East and Africa
|
396.6
|
352.5
|
+12.5%
|
1.5%
|
|
Americas
|
335.9
|
280.5
|
+19.7%
|
2.6%
|
|
Asia-Pacific
|
171.1
|
153.0
|
+11.8%
|
7.2%
|
|
Revenue
|
903.4
|
786.0
|
+14.9%
|
3.0%
|
|
Ipsos recorded 'significant revenue growth' in all regions, driven primarily by the acquisition of certain divisions of
GfK and
Synthesio at the end of 2018. The firm also experienced 'encouraging organic growth', which was strongest in Asia-Pacific and reached a 'record high' in the Americas.
According to the firm, major markets including the US, UK, China, France, Russia, Turkey and India are all doing well, supported by demand from both international and local clients. Developing countries saw a greater rate of growth than developed countries, with like-for-like growth over H1 2019 of 5.9% and 1.6%, respectively. In Q2, organic growth for developing and developed countries came out at 5.9% and 2.4%, respectively.
Performance by Audience
Performance by Audience
|
(In millions of Euros) |
H1 2019 |
Total YoY |
H1 growth |
Organic growth |
|
Consumers
|
432.4
|
48%
|
6.9%
|
1%
|
|
Clients and Employees
|
213.7
|
24%
|
17.8%
|
3%
|
|
Citizens
|
122.2
|
14%
|
34.0%
|
10%
|
| Doctors and Patients |
135.0 |
15% |
24.0% |
8% |
|
Annual Revenue
|
903.4
|
100%
|
14.9%
|
3.0%
|
|
Breakdown of each business line by segment:
1 - Brand Health, Clinics & Mobility Labs, Creative Excellence, Innovation, Ipsos UU, Ipsos MMA, Market Strategy & Understanding, Observer, Social Intelligence Analytics (excl. pharma and the public sector)
2 - Customer Experience, Market Measurement, Mystery Shopping, Quality Measurement, Retail Performance, ERM, Audience Measurement, Media Development
3 - Public Affairs, Corporate Reputation
4 - Pharma (quantitative and qualitative
In the first quarter of 2019, operations involving 'citizens' was a main driver of growth, while the pharmaceutical business bounced back from a dip in 2018 with organic growth of 8%.
Outlook for 2019
In a statement, Ipsos said it had decided in spring 2018 to completely overhaul its structure, having struggled with 'stagnating' levels of business and profitability despite its scale, extensive geographic and sectoral coverage, and its efforts to develop new ways of working. 'Today', the firm says, 'Ipsos is confident regarding the launch and implementation of its global 'Total Understanding' programme and therefore in its ability to once again return to a consistent, profitable cycle of growth'.
Web site:
www.ipsos.com .
All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.
